HIF-1α Regulates Bone Homeostasis and Angiogenesis, Participating in the Occurrence of Bone Metabolic Diseases

Abstract

In the physiological condition, the skeletal system’s bone resorption and formation are in dynamic balance, called bone homeostasis. However, bone homeostasis is destroyed under pathological conditions, leading to the occurrence of bone metabolism diseases. The expression of hypoxia-inducible factor-1α (HIF-1α) is regulated by oxygen concentration. It affects energy metabolism, which plays a vital role in preventing bone metabolic diseases. This review focuses on the HIF-1α pathway and describes in detail the possible mechanism of its involvement in the regulation of bone homeostasis and angiogenesis, as well as the current experimental studies on the use of HIF-1α in the prevention of bone metabolic diseases. HIF-1α/RANKL/Notch1 pathway bidirectionally regulates the differentiation of macrophages into osteoclasts under different conditions. In addition, HIF-1α is also regulated by many factors, including hypoxia, cofactor activity, non-coding RNA, trace elements, etc. As a pivotal pathway for coupling angiogenesis and osteogenesis, HIF-1α has been widely studied in bone metabolic diseases such as bone defect, osteoporosis, osteonecrosis of the femoral head, fracture, and nonunion. The wide application of biomaterials in bone metabolism also provides a reasonable basis for the experimental study of HIF-1α in preventing bone metabolic diseases.

Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma

“…Notch1 controls angiogenesis by modulating endothelial cell fate determination during angiogenesis ( Liu et al, 2003 ; Ye et al, 2023 ). A variety of angiogenic signaling pathways are regulated by Notch1, such as VEGF ( Chen et al, 2022 ; Kangsamaksin, Tattersall & Kitajewski, 2014 ). NOTCH1 plays an important role in oral squamous cell carcinoma angiogenesis.…”

Role of Trimetazidine in Ameliorating Endothelial Dysfunction: A Review

“…These events result in reduced expression of genes associated with proliferation and survival. HIF serves as a transcription factor governing cellular responses to hypoxia, including angiogenesis and cell survival [ 77 ].…”

Bone repair and key signalling pathways for cell-based bone regenerative therapy: A review

“… 75 , 76 p38MAPK Osteoblast differentiation regulator An important regulator of early bone formation and development. p38 bound to BMP2/7 contributes to Runx2 and Osx transcriptional activity 77 , 78 ERK1/2 Osteoblast differentiation factor Regulates lineage specification into osteoblast and osteoclast differentiation 79 Intracellular messengers Runx2 Osteogenic transcription factor Also known as core-binding factor subunit alpha-1 (Cbfa1) , an important transcription factor that regulates the expression of major bone matrix protein genes through osteoblast-specific cis -acting element (OSE2), a direct binding site in the promoter of several osteoblast-specific genes. 80 Osterix ( Osx ) Osteoblast-specific transcription factor Also known as transcription factor Sp7.…”

“…Another multiprotein complex of mTOR which is mTORC1 also involves in the regulation of protein synthesis in the cell through p70S6K1. 77 Activation of mTORC1 modulates osteoblast differentiation by regulating Runx2 expression through augmentation of Runx2 enhancer activity. 78 The only difference between mTORC1 and mTORC2 is the complex component where mTORC1 consists of Raptor and is sensitive to rapamycin, whereas mTORC2 comprises Rictor which is insensitive to rapamycin.…”